SM Javad Mortazavi - Orthopedic Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
Seyyed Mohammad Mehdi Daneshpoor - Orthopedic Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
Seyyed Hossein Shafiei - Orthopedic Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran

Total hip arthroplasty (THA) is the mainstay therapy for terminally hemophilic arthropathy patients.Hemophilic patients have distinguishing characteristics, including the increased likelihood of bleeding, younger age, restricted pre-operative joint motion, disrupted anatomy, and more post-operative side effects. The present study aimed to assess the THA sequels in hemophilic patients from various perspectives, including indications, challenges, factor replacement post-operative outcomes, and other complications. Level of evidence: V

Hemophilia, hemophilic arthropathy, Total hip arthroplasty